ANL (Adlai Nortye) Total Operating Expense: $40.70 Mil (TTM As of Dec. 2025)


What is Adlai Nortye Total Operating Expense?

Adlai Nortye ANL -10.47% Total Operating Expense is $40.70 Mil as of Dec. 2025. The stock has 7 warning signs investors should review.

Adlai Nortye's Total Operating Expense for the six months ended in Dec. 2025 was $21.52 Mil. Adlai Nortye's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was $40.70 Mil.

Adlai Nortye Total Operating Expense Related Terms

Adlai Nortye Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Adlai Nortye's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adlai Nortye Total Operating Expense Chart

Adlai Nortye Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
54.37 67.27 72.55 52.93 40.70

Adlai Nortye Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only 40.43 29.24 23.69 19.17 21.52

Adlai Nortye Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $40.70 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $40.70 Mil mean?
Adlai Nortye (ANL) has a Total Operating Expense of $40.70 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on Adlai Nortye and its competitors.
Is Adlai Nortye's Total Operating Expense too high?
Adlai Nortye's current Total Operating Expense is $40.70 Mil.
How does Adlai Nortye's Total Operating Expense compare to OMER and PRME?
Adlai Nortye's Total Operating Expense of $40.70 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Adlai Nortye and its competitors. Adlai Nortye's current Total Operating Expense is $40.70 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adlai Nortye stock overvalued right now?
Adlai Nortye (ANL) has a current Total Operating Expense of $40.70 Mil. The current Total Operating Expense is $40.70 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Adlai Nortye (ANL), the current Total Operating Expense is $40.70 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Adlai Nortye Business Description

Other Exchanges N2U0:Germany
Address 685 US Highway 1, New Jersey Biotechnology Development Center, 2nd Floor, North Brunswick, NJ, USA, 08902
Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.